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Abstract
Background: Gap junctions increase in size and abundance coincident with parturition, forming
an intercellular communication network that permits the uterus to develop the forceful,
coordinated contractions necessary for delivery of the fetus. Lindane, a pesticide used in the human
and veterinary treatment of scabies and lice as well as in agricultural applications, inhibits uterine
contractions in vitro, inhibits myometrial gap junctions, and has been associated with prolonged
gestation length in rats. The aim of the present study was to investigate whether brief exposures
to lindane would elicit sustained inhibition of rat uterine contractile activity and myometrial gap
junction intercellular communication.
Methods: To examine effects on uterine contraction, longitudinal uterine strips isolated from late
gestation (day 20) rats were exposed to lindane in muscle baths and monitored for changes in
spontaneous phasic contractions during and after exposure to lindane. Lucifer yellow dye transfer
between myometrial cells in culture was used to monitor gap junction intercellular communication.
Results: During a 1-h exposure, 10 micro M and 100 micro M lindane decreased peak force and
frequency of uterine contraction but 1 micro M lindane did not. After removal of the exposure
buffer, contraction force remained significantly depressed in uterine strips exposed to 100 micro
M lindane, returning to less than 50% basal levels 5 h after cessation of lindane exposure. In cultured
myometrial myocytes, significant sustained inhibition of Lucifer yellow dye transfer was observed
24 h after lindane exposures as brief as 10 min and as low as 0.1 micro M lindane.
Conclusion: Brief in vitro exposures to lindane have long-term effects on myometrial functions
that are necessary for parturition, inhibiting spontaneous phasic contractions in late gestation rat
uterus and gap junction intercellular communication in myometrial cell cultures.
Background
Relatively few studies have examined toxicant actions on
uterine muscle, despite widespread recognition that regu-
lation of uterine muscle contractility is fundamental for
successful pregnancy [1]. Recent studies suggest that some
toxicants inhibit uterine contraction by a mechanism that
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involves inhibition of uterine muscle gap junctions [2–4].
Gap junctions are intercellular channels that allow the
passage of low molecular weight molecules, thereby facil-
itating electrical and metabolic communication between
cells [5]. It is suggested that gap junctions play an essential
role in parturition by providing low resistance pathways
for propagation of depolarizing signals that ultimately
coordinate the contractions of the myometrium [6].
The pesticide lindane (γ-hexachlorocyclohexane) inhibits
spontaneous uterine contractions in vitro. Specifically, in
vitro exposure of longitudinal uterine strips isolated from
midgestation (day 10) rats to cumulative concentrations
of lindane at 10-min intervals depresses spontaneous con-
tractions in a concentration-dependent manner with an
ED50 of 9.2 µM lindane and abolishes contractions at 30
µM lindane [7]. Furthermore, acute in vitro exposure to
lindane (1–100 µM) inhibits gap junction communica-
tion in rat myometrial smooth muscle cells in culture [8].
Studies suggest that activation of phospholipase C and
generation of reactive oxygen species may be mechanistic
links between lindane-induced inhibition of myometrial
gap junctions and inhibition of uterine contractility [2,4].
Lindane (γ-hexachlorocyclohexane) acts as an insecticide
by inducing hyperexcitability [9–11]. Current and past
uses of lindane provide opportunities for exposure of
pregnant women to lindane. Lindane is used as a pharma-
ceutical treatment of scabies and lice in human medicine.
It is estimated that up to1 million prescriptions for lin-
dane, dispensed as a 1% lotion or shampoo, are written
annually for the treatment of lice and scabies in the
United States [12]. Although widely used in the past as an
insecticide in a variety of agricultural, forestry and house-
hold applications, the United States currently restricts lin-
dane insecticide use to certain seed treatments [13] and
the European Union has banned all agricultural uses of
lindane [14]. Commercial production of lindane in the
USA has not been reported since 1976 [15]. Nonetheless,
environmental media remain contaminated with lindane
due to its lipophilicity, persistence in the environment
and widespread past usage. For example, lindane is a con-
taminant of 163 of the 1,467 current or former U.S. EPA
National Priorities List hazardous waste sites [15] and lin-
dane was detected in 55% of dairy milk samples from
widespread regions of India, despite a ban in lindane pro-
duction and phasing out of lindane's use in India since
1997 [16].
A few studies of women with no known personal, occupa-
tional or accidental exposure to lindane provide some
insight into exposures of pregnant women to lindane. A
recent study showed that women in India who delivered
babies exhibiting intrauterine growth retardation had
maternal blood concentrations averaging 6.30 ± 7.51 ppb
(n  = 29) lindane at term, excluding an "exceptionally
high" value of 365 ppb in one sample, compared to an
average maternal blood concentration of 2.65 ± 2.15 ppb
(n = 24) lindane in women who delivered normal weight
babies [17]. In an earlier study, concentrations of lindane
at the time of delivery ranged from 7 to 136 ppb in mater-
nal blood of 50 women in India [18].
Similar to the finding that intrauterine growth retardation
is associated with elevated maternal blood concentrations
of lindane [17], women occupationally exposed to wood
preservative mixtures that included lindane gave birth to
babies with reduced birthweights and body lengths [19].
Further supporting evidence for lindane effects on intrau-
terine growth comes from laboratory animal studies, with
decreases in fetal weight observed in mice administered
single oral doses on day 12 of gestation of 30 or 45 mg lin-
dane/kg body weight [20]. Moreover, lindane increased
embryolethality in minks fed 1 mg/kg/day lindane in the
diet [21], and increases of embryolethality were observed
in mice exposed to technical-grade hexachlorocyclohex-
ane (which includes lindane) administered to the mother
during gestation [22,23]. A dose of 20 mg lindane/kg
body weight increased the incidence of fetuses with an
extra rib in rats exposed during gestation days 6–15 and in
rabbits exposed during gestation days 6–18 [24]. How-
ever, developmental anomalies or malformations were
not observed in studies of mice exposed to 30 and 45 mg
lindane/kg/day during gestation days 6–12 [20], in mice
exposed to a single oral dose of 25 mg technical-grade
hexachlorocyclohexane/kg [22]and in rats exposed during
gestation to 25 and 50 mg technical-grade hexachlorocy-
clohexane/kg/day [25]. A recent study found that male
mice exposed prenatally to 25 mg lindane/kg body weight
during gestation days 9–16 exhibited postnatal changes in
spermatogenesis that reversed with age [26]. Together, the
human and animal studies suggest a link between lindane
exposure during pregnancy and fetal effects.
There are no previous reports of lindane actions on late
gestation uterine muscle activity, yet inhibition of uterine
contraction would likely have the greatest physiological
consequences near term. Furthermore, although a previ-
ous report showed that brief exposure to lindane inhibits
myometrial gap junctions for up to 24 h [2], there are no
reports of sustained actions on uterine contraction after
brief exposures to lindane. The present study investigated
whether brief exposures to lindane would elicit sustained
inhibition of rat uterine contractile activity in late gesta-
tion (day 20) uterine strips and gap junction intercellular
communication in myometrial cell cultures. Concentra-
tions used in the present study ranged from 1–100 µM lin-
dane in the contractility experiments and 0.01–100 µM
lindane in the cell culture experiments. Concentrations in
the 0.01–1 µM range correspond to concentrations withinReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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ranges observed in the blood of pregnant women with no
known personal, occupational or accidental exposure to
lindane [18,27]. Brief (<1 h) exposures to lindane inhib-
ited both spontaneous phasic uterine contraction and




The  γ-isomer of hexachlorocyclohexane (lindane, 99%
purity) was obtained from Sigma Chemical Co. (St. Louis,
MO). The dyes Lucifer yellow and propidium iodide were
obtained from Molecular Probes (Eugene, OR). Myome-
trial cells were cultured in RPMI medium obtained from
Gibco (Grand Island, NY). The medium was supple-
mented with 10% iron-enriched bovine calf serum
(HyClone, Logan, UT). All other chemicals were obtained
from Sigma Chemical Co.
Animals
Rats were housed at 24 ± 1°C under a 12-h light schedule.
Female Sprague-Dawley rats between 60 and 90 days of
age and weighing 180 to 220 g were mated in the colony
of the Reproductive Science Program at the University of
Michigan. The day of detection of sperm in the vaginal
smear was designated as day 0 of pregnancy. Animal hous-
ing and handling procedures complied with institutional
and NIH guidelines for care and use of laboratory animals
in research.
Uterine contractility assessment
Sprague-Dawley rats were anesthetized on gestation day
20 with ether (required by a collaborator who used other
tissue from the animals) and sacrificed by exsanguination.
Uteri were excised, and embryos and fat were removed
from both uterine horns. Longitudinal strips (2 mm × 20
mm) were excised from the midsection of each uterine
horn. The strips were suspended in 50-ml muscle baths
(custom-made by the University of Michigan Glass Shop)
that contained prewarmed (37°C) calcium-containing
physiologic saline solution (PSS; 116 mM NaCl, 4.6 mM
KCl, 1.16 mM NaH2PO4•H2O, 1.16 mM MgSO4•7H2O,
21.9 mM NaHCO3, 1.8 mM CaCl2•2H2O, 11.6 mM dex-
trose, 2.6 mM EDTA, pH 7.4). The muscle baths and
buffer reservoirs were continuously bubbled with a gas
mixture of 95% O2/5% CO2. To record isometric contrac-
tions, one end of each muscle strip was tied with surgical
silk to a stationary post while the other end was tied to a
force transducer (Grass FT-03, Quincy, MA). Changes in
contractile activity were recorded on a strip chart poly-
graph. All strips were subjected to a 19.6 mN preload ten-
sion and allowed to equilibrate at 37°C until regular
phasic contractions developed (2–4 h). These conditions
had been established in preliminary experiments as opti-
mal for allowing development of spontaneous phasic
contractions in the muscle bath. Strips then were exposed
to 0.2% DMSO (solvent control), or to 1, 10 or 100 µM
lindane for 1 h (n = 7), rinsed three times with fresh phys-
iologic saline solution, and monitored an additional 5 h
in lindane-free buffer to determine lindane's long-term
effects on spontaneous uterine contractions. A contrac-
tion was operationally defined as an increase in force that
initiated at baseline, exceeded 25% of average basal force,
and returned to baseline. The maximum force displace-
ment per contraction and the number of uterine contrac-
tions/min were used to calculate the average peak force
and frequency of uterine contractions for 30-min inter-
vals. The average peak force and number of contractions/
min measured during the 30-min period immediately
prior to exposure were used as the basal contraction force
and frequency. The contraction force and frequency values
for the exposure and post-exposure intervals were
expressed as percent of basal values to adjust for variations
between individual uterine strips. The average contraction
force and frequency were calculated for both 30-min
intervals during the 1-h lindane exposure and for the last
30 min of each hour during the 5-h post-exposure period.
Analyses were not conducted beyond 5 h to avoid con-
founding of the results with decline of health of the tissue
in the muscle bath.
Cell isolation and culture
Myometrial smooth muscle cells were isolated from gesta-
tion day 10 Sprague-Dawley rats by methods previously
described [28]. It has previously been shown that myome-
trial cell cultures prepared by this method express
connexin43 gap junction protein [29]. Because myome-
trial cells establish functional gap junctions in culture
regardless of whether the cells are isolated from midgesta-
tion or late gestation uterus [28], cells were isolated from
midgestation uteri to take advantage of an opportunity
reduce the number of animals killed by sharing animals
with another investigator. Cells were seeded into flasks
containing RPMI medium supplemented with 10%
bovine calf serum and maintained at 37°C in a 5% CO2
atmosphere. Growth medium was changed every 1–2
days. Cells were subcultured every 3–4 days prior to reach-
ing confluence. The smooth muscle character of the cul-
tured cells was verified using indirect
immunofluorescence labeling with mouse anti-a-smooth
muscle-specific actin monoclonal antibody as previously
described [28], and exceeded 99%.
Lucifer yellow dye microinjection and transfer
Myometrial cells were removed from flasks by exposure to
0.25% crude trypsin at 37°C for 5 min. Cells were then
seeded into 35-mm dishes containing 3 ml of RPMI
medium supplemented with 10% bovine calf serum at a
density of 50–60 × 103 cells/dish. The cells were incubated
for 24 h at 37°C in a 5% CO2 atmosphere to allow forReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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attachment and growth. A mixed dye solution containing
0.9% (w/v) Lucifer yellow and 0.2% propidium iodide
was prepared in a calcium-free and magnesium-free phos-
phate buffered saline and utilized to assess dye transfer.
Lucifer yellow, a hydrophilic fluorescent dye with a low
molecular weight, was used to monitor gap junction com-
munication. In contrast, propidium iodide rapidly reacts
with the DNA of the nucleus and serves as a marker of the
injected cell. Medium was replaced with phosphate buff-
ered saline (0.9 mM CaCl2, 2.68 mM KCl, 1.47 mM K3PO4
(monobasic), 0.5 mM MgCl2 (hexahydrate) and 8 mM
Na3PO4 (dibasic heptahydrate) supplemented with 5 mM
glucose prior to microinjection of the cells. An injection
pressure of 6.5 psi for 200 msec was used for each injec-
tion pulse of dye (one pulse/injected cell). Scoring con-
sisted of visual detection of Lucifer yellow dye in cells in
direct contact with the injected cell, using an epifluores-
cence microscope (Nikon Diaphot) equipped with a G2A
filter (510–560-nm excitation and 590-nm barrier) to
detect propidium iodide fluorescence and a B2A filter
(450–490-nm excitation and 520-nm barrier) to detect
Lucifer yellow fluorescence.
Statistical analysis
The dye transfer and contractility data were transformed
by the arcsine transformation to correct for the nonnor-
mal distribution of percentage data, then analyzed by
one-way or two-way analysis of variance (ANOVA), as
appropriate, using SigmaStat software (Jandel Scientific,
San Rafael, CA). Because uterine strips were sampled over
time, the contractility data were analyzed by repeated
measures ANOVA with time as the repeated measure.
Posthoc pair-wise comparisons of means were performed
by the Student-Newman-Keuls method. A p-value ≤ 0.05
was considered statistically significant.
Results
Uterine contraction
Figure 1A shows representative polygraph tracings of mus-
cle contractions of gestation day (GD) 20 uterine strips
before and during exposure to 0.2% DMSO (solvent con-
trol) or 1, 10 or 100 µM lindane. These concentrations of
lindane were selected based upon previous reports that
this was an effective concentration range for inhibition of
contractions in GD10 uterine strips [7] and for inhibition
of gap junction intercellular communication between
myometrial myocytes in culture [8,30]. As seen in Figure
1A, the addition of 10 µM or 100 µM lindane, but not 1
µM lindane or DMSO (solvent control), rapidly decreased
the peak amplitude (force) of spontaneous phasic con-
tractions. Inherent differences between uterine strips in
basal contractility were not uncommon, as seen in the
examples in Figure 1. Consequently, to quantify changes
in contractions, the data were expressed as percent basal
contraction force for individual strips prior to summariza-
tion, as described in Methods.
Uterine strips treated with solvent (controls) or 1 µM lin-
dane showed no significant differences in peak contrac-
tion force or frequency during the 1-h exposure (Fig. 2). In
contrast, the average peak force and frequency of contrac-
tion decreased in concentration-dependent (ANOVA, p ≤
0.001) and time-dependent (ANOVA, p ≤ 0.001) manners
during 1-h exposures to 10 µM or 100 µM lindane (Fig. 2).
During the first half hour of exposure, the average peak
force of contraction was depressed by 100 µM lindane to
60.8 ± 4.0 %, a significant decrease in comparison with
the 100 µM lindane group basal (pretreatment) and the
time-matched 1 µM lindane treatment group (95.1 ± 1.6
%) (Fig. 2A, p  ≤ 0.05), but not compared with time-
matched solvent (DMSO) controls (87.6 ± 9.7 %). During
the 0.5–1 h exposure period, the average peak force of
contraction was further depressed by 10 µM to 11.7 ±
5.5% and by 100 µM lindane to 0.0 ± 0.0 %, significantly
different from the preceding 0–0.5 h exposure period for
each respective lindane treatment, time-matched solvent
(DMSO) controls (94 ± 10.3%), and the time-matched 1
µM lindane treatment group (97.8 ± 2.7 %) (Fig. 2A, p ≤
0.05).
Lindane effects on contraction frequency were not as pro-
nounced as the effects on contraction force. No significant
lindane effects on contraction frequency were observed
during the first half hour of lindane exposure (Fig. 2B).
During the 30–60 min exposure interval, contraction fre-
quency decreased in uterine strips treated with 10 µM lin-
dane to 64.1 ± 3.1% and with 100 µM lindane to 0.0 ±
0.0%, significantly depressed compared with time-
matched solvent (DMSO) controls (108.4 ± 9.8%), the
respective basal (pretreatment) for each respective lindane
treatment, and the preceding 0–0.5 h exposure period for
each respective lindane treatment (Fig. 2B, p ≤ 0.05).
The percentage of uterine strips still contracting following
exposure to 10 µM lindane was reduced in a time-depend-
ent manner, with only 1 of 7 treated uterine strips (14%)
still contracting at the end of the 1-hr exposure period.
Exposure to 100 µM lindane induced an even more pro-
nounced reduction in uterine contractions with only 1 of
7 treated strips (14%) exhibiting phasic contractions after
20 min and cessation of all uterine contractions after 30
min (Fig. 3). These contractility results show that lindane-
induced inhibition of spontaneous phasic uterine con-
tractions increased with increased duration of exposure.
The buffer was removed after 1 h of exposure, uterine
strips were rinsed, and fresh buffer without lindane was
added to the muscle baths. Uterine strips were allowed 30
min to redevelop phasic patterns before assessment ofReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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force and frequency during the post-exposure recovery
period. Representative polygraph tracings in Figure 1B
show that by 3 h after rinsing, uterine strips treated with
DMSO (solvent control), 1 µM lindane or 10 µM lindane
exhibited contractions similar to pretreatment (basal),
but that strips treated with 100 µM lindane contracted
with decreased force.
After rinsing, contractile force and frequency recovered in
lindane-treated strips in concentration-dependent and
time-dependent manners (ANOVA, p ≤ 0.001; Fig. 4). In
control uterine strips exposed to solvent (DMSO) alone
and in strips exposed to 1 µM lindane, neither the force
nor frequency of contraction varied significantly over the
5-h post-exposure observation period (Fig. 4). Uterine
strips rapidly recovered from the 1-h exposure to 10 µM
lindane, generating contractions within 1 h after rinsing
(during the 0.5–1 h interval) with an average peak con-
traction force (65.8 ± 5.9%) and average frequency of con-
traction (100.9 ± 18.4 %) that were not statistically
different from time-matched solvent (DMSO) control
averages for force (86.8 ± 13.2%) and frequency (71.9 ±
14.6 %) (Fig. 4A).
In contrast, uterine strips exposed to 100 µM lindane ini-
tially remained quiescent after rinsing, exhibiting no
Representative polygraph tracings of longitudinal muscle strips Figure 1
Representative polygraph tracings of longitudinal muscle strips. Uterine strips were isolated from uteri of gestation 
day 20 rats and exposed in muscle baths to 0.2% DMSO (solvent control) or 1, 10 or 100 µM lindane for 1 h. After exposure, 
the strips were rinsed 3 times and monitored in fresh physiological salt solution without test chemicals for an additional 5 h. A) 
Five minutes prior to exposure and 30 min after initiating a 1-h exposure (arrows mark addition of test chemical). B) 4.5 hours 
after rinsing (10 min shown).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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contractions during the 0.5-1 h period after rinsing (Fig.
4A and 4B). Force of contraction remained depressed for
the entire 5-h post-exposure observation period in the
uterine strips treated with 100 µM lindane, with partial
recovery in the 3.5–4 h and 4.5–5 h intervals to average
peak contraction force of 36.4 ± 10.1 % and 39.9 ± 11.1
%, respectively, significantly elevated compared with the
0.5–1 h interval but remaining significantly depressed
compared with time-matched solvent (DMSO) controls
(105.4 ± 11.6 %) (Fig. 4A, p ≤ 0.05). In contrast to the sus-
tained inhibition of contraction force by 100 µM lindane,
frequency of contraction recovered from complete quies-
cence in the 0.5–1 h post-treatment period to 29.1 ± 2.2%
in the 1.5 – 2 h period, an average frequency not signifi-
cantly different from time-matched solvent (DMSO) con-
trols (Fig. 4B). The frequency of contraction increased
further to 62.6 ± 2.6% during the 2.5–3 h period and
remained at this level for the remaining 2 h of observa-
tion. These contractility results show that lindane inhib-
ited spontaneous phasic contractions in GD20 uterine
strips in vitro and that this inhibition increased with con-
centration and duration of exposure to lindane.
Lucifer yellow dye transfer
Lucifer yellow dye transfer was used to assess sustained
effects of lindane on myometrial gap junctions. Figure
5A,5B,5C shows an example of Lucifer yellow dye transfer
in a control myometrial cell culture. Because 100 µM lin-
dane abolished uterine contraction force in a sustained
manner in the contractility experiments, this concentra-
tion of lindane was used in initial time-course dye transfer
experiments.
At the end of a 1-h exposure to 100 µM lindane and before
rinsing, Lucifer yellow dye transfer was abolished between
myometrial cells in culture (Fig. 6, zero time point), as
expected based on previous reports [8,30]. After rinsing,
Time- and concentration-related effects of lindane on uterine  contraction force (A) and frequency (B) Figure 2
Time- and concentration-related effects of lindane on 
uterine contraction force (A) and frequency (B). 
Uterine strips were exposed to lindane (1, 10 or 100 µM) as 
described in Figure 1. The average peak force of contraction 
and the average frequency of contraction were calculated 
relative to basal (pretreatment) values, as described in Meth-
ods, over 30-min intervals of a 1-h exposure. Changes in 
contraction force and frequency were analyzed by separate 
repeated measures analysis of variance (ANOVA) for con-
centration, exposure duration, and interaction effects, with 
repeated measures on exposure duration. Lindane decreased 
uterine contraction frequency and force in concentration-
dependent and time-dependent manners, with a significant 
interaction between concentration and exposure duration 
(ANOVA, p ≤ 0.001). Vertical bars with different letters have 
means that are significantly different from each other in pair-
wise comparisons (Student-Newman-Keuls, p ≤ 0.05). Values 
shown are mean ± SEM of 7 uterine strips. Error bars not 
visible are too small to be displayed graphically.
Time- and concentration- related effects of treatment on  percent uterine strips contracting during exposure (1 h) Figure 3
Time- and concentration- related effects of treat-
ment on percent uterine strips contracting during 
exposure (1 h). Uterine strips were exposed to lindane as 
described in Figure 1. Data are expressed as the percentage 
of strips retaining phasic contractions at the end of a 1-h 
exposure to lindane or DMSO (solvent control).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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intercellular transfer Lucifer yellow dye initially improved
before declining again (Fig. 6, ANOVA, p  ≤ 0.0001).
Within 30 min after rinsing, dye transfer had recovered to
99.5 ± 0.5% (p ≤ 0.05 compared with zero time point), a
level similar to that observed in solvent control cultures
assessed 24 h after a 1-h exposure (98.4 ± 1.7%, data not
shown on graph). However, dye transfer declined in the
lindane-exposed cell cultures in a time-dependent man-
ner to 81.6 ± 1.8% after 1 h (p ≤ 0.05 compared with 0.5
h after rinsing), and reached a minimum by 4 h that per-
sisted for 24 h (p ≤ 0.05 compared with 0, 0.5, 1 and 2 h
after rinsing; Fig. 6). This pattern of dye transfer indicates
that lindane-induced inhibition of myometrial gap junc-
tion communication, as measured by Lucifer yellow dye
transfer, was initially rapidly reversible, but that a second-
ary and sustained inhibition of dye transfer developed in
the absence of further exposure to lindane after a brief
delay.
Subsequent experiments determined the effect of expo-
sure duration on sustained inhibition of dye transfer by
lindane. Lindane decreased dye transfer to similar extents
regardless of whether the duration of exposure was 10
min, 1 h or 24 h (Fig. 7, ANOVA, p  ≤ 0.0001). The
decrease in dye transfer was statistically greater in the cul-
tures exposed to lindane for 1 h or 24 h compared with
cultures exposed for 10 min, although the magnitude of
the difference was modest (p ≤ 0.05). There were no signif-
icant differences in dye transfer between cultures exposed
to lindane for 1 h or 24 h. These results show that an expo-
sure as brief as 10 min to 100 µM lindane was sufficient to
inhibit Lucifer yellow dye transfer 24 h later.
The effect of exposure duration on lindane-induced inhi-
bition of Lucifer yellow dye transfer was examined further
in an experiment that included concentrations ranging
from 0.01 µM to 100 µM lindane. As shown in Figure 8,
lindane significantly inhibited dye transfer in similar con-
centration-dependent manners 24 h after a 1-h exposure
or after a 24-h continuous exposure (ANOVA, p ≤ 0.0001).
Regardless of whether exposure was for 1 h or 24 h, 0.01
µM lindane had no significant effect on dye transfer 24 h
after initiating exposure. In contrast, 0.1 µM lindane sig-
nificantly depressed dye transfer to 81.1 ± 3.1% and 81.6
± 3.1% 24 h after initiating exposure for 1 h or 24 h,
respectively, compared with solvent controls (Fig. 8, p ≤
0.05). Dye transfer was depressed further in cultures
exposed to 1, 10 or 100 µM lindane compared with con-
trols and 0.01 µM lindane (p ≤ 0.05), although a concen-
tration-dependent response was not observed in this
concentration range (Fig. 8). These results show that brief
(1 h) and extended (24 h) exposures to lindane inhibited
myometrial gap junction communication to similar
extents, as measured by Lucifer yellow dye transfer, and
that a low concentration of lindane (0.1 µM) inhibited
myometrial gap junction communication in a sustained
manner. There was not a significant difference between
the percentage of cells excluding trypan blue in the solvent
(DMSO) control and the 100 µM lindane treatment group
24 h after exposure (data not shown), indicating an
absence of overt cytotoxicity.
Time- and concentration-related effects of lindane on con- traction force (A) and frequency (B) during recovery Figure 4
Time- and concentration-related effects of lindane on 
contraction force (A) and frequency (B) during 
recovery. Uterine strips were exposed to lindane (1, 10 or 
100 µM) as described in Figure 1. The average peak force of 
contraction and the average frequency of contraction were 
calculated relative to basal (pretreatment) values, as 
described in Methods, over 30-min intervals of a 5-h recov-
ery period beginning 30 min after removal of the lindane 
exposure buffer (rinsing). Changes in contraction force and 
frequency were analyzed by separate repeated measures 
analysis of variance (ANOVA) for concentration, time, and 
interaction effects, with repeated measures on time. Con-
traction frequency and force recovered from lindane-induced 
inhibition in concentration-dependent and time-dependent 
manners, with a significant interaction between concentra-
tion and time (ANOVA, p ≤ 0.001). Vertical bars with differ-
ent letters have means that are significantly different from 
each other in pair-wise comparisons (Student-Newman-
Keuls, p ≤ 0.05). Values shown are mean ± SEM of 7 uterine 
strips. Error bars not visible are too small to be displayed 
graphically.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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Discussion
During pregnancy, inhibition of uterine contraction
would be expected to have its greatest physiological impli-
cations in late gestation through the impairment of
uterine contractions necessary for parturition. Previous
studies in our laboratory showed that acute exposures to
lindane inhibit spontaneous phasic contractions of
midgestation (GD10) rat uteri [7]. The present report pro-
Lucifer yellow dye transfer between myometrial cells in culture Figure 5
Lucifer yellow dye transfer between myometrial cells in culture. Lucifer yellow dye injected into a single cell (arrow) 
transferred to neighboring recipient cells. A, phase contrast. B, epifluorescence showing propidium iodide fluorescence mark-
ing the injected donor cell. C, epifluorescence showing Lucifer yellow fluorescence in donor and recipient cells.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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vides the first observation that lindane inhibits contrac-
tions in late-gestation (GD20) uteri. Similar to its actions
in myometrium, lindane inhibits contractions in
intestinal smooth muscle [31] and vas deferens [32,33],
suggesting that lindane-induced inhibition of contractility
may be common to smooth muscle.
Myometrial gap junctions improve coordination and
increase the force of uterine contraction during parturi-
tion [34,35], whereas inhibition of myometrial gap junc-
tion intercellular communication is associated with
decreased uterine contractility [2,36]. Consistent with lin-
dane-induced inhibition of spontaneous phasic uterine
contractions, lindane abolished gap junction
communication between myometrial cells in culture as
measured by Lucifer yellow dye transfer. This result agrees
with previous studies that showed lindane-induced inhi-
bition of gap junction communication in rodent hepato-
cytes [37–39], Chinese hamster V79 fibroblasts [40], rat
oocytes [41] and rat myometrial myocytes [8,30] at simi-
lar concentrations.
A brief exposure (1 h) to a sufficient concentration (100
µM) of lindane exerted long-term inhibition of uterine
muscle function. This is the first report that lindane inhib-
its uterine contraction in a sustained manner. The partial
recovery of uterine contractions from a 1-h exposure to
100 µM lindane (albeit with average peak force of contrac-
tion less than 50 % of basal /pretreatment values) suggests
that the sustained inhibition is not due to irreversible cell
damage. Moreover, complete recovery of contraction
force was observed by 1 h after exposure to 10 µM
lindane, even though contractions were abolished in 6 of
the 7 uterine strips during lindane exposure. In cultured
myometrial cells, no increase of cell death was detected 24
h after a 1-h exposure to 100 µM lindane, providing fur-
Time-dependent effects on Lucifer yellow dye transfer after exposure to lindane Figure 6
Time-dependent effects on Lucifer yellow dye transfer after exposure to lindane. A 1-h treatment of rat myome-
trial cells with 100 µM lindane initially abolished Lucifer yellow dye transfer (zero hour time-point), and then after removal of 
lindane exposure buffer and rinsing, this inhibition first reversed before redeveloping (ANOVA, p ≤ 0.0001). Mean values ± 
S.E.M. are shown (n = 3–5 culture dishes; 8–14 cells were injected per dish). Vertical bars with different letters have means that 
are significantly different from each other in pair-wise comparisons (Student-Newman-Keuls, p ≤ 0.05). Cultures exposed to 
solvent (DMSO) alone for 1 h were assessed 24 h after rinsing, and were found to transfer dye to 98.4 ± 1.7% of neighboring 
cells (data not shown on graph).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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ther suggestion that the sustained contraction response to
lindane was not mediated by irreversible cell damage. Fur-
thermore, preliminary in vivo/in vitro experiments in our
laboratory showed that uterine strips excised from preg-
nant rats exposed to 6 mg lindane /kg s.c. on GD19 exhib-
ited depressed uterine contractility compared with solvent
controls when removed to muscle baths 24 h later (Brant,
Grindatti and Loch-Caruso, unpublished).
The present study provides the first demonstration that a
very brief (10 min) exposure to lindane is sufficient to
induce sustained inhibition of myometrial gap junction
intercellular communication. Moreover, the sustained
inhibition of gap junction intercellular communication
by concentrations as low as 0.1 µM lindane agrees with
published observations in myometrial cells [2], although
sustained inhibition of gap junction intercellular commu-
nication was not observed in rat liver cell cultures exposed
to lindane [39]. The pattern of recovery differed for lin-
dane-induced inhibition of uterine contractility and
myometrial gap junctions. Whereas uterine strips partially
regained contractility with time after removal of lindane
exposure buffer, cells showed an initial rapid, but tran-
sient, reversal of dye transfer inhibition after removal of
lindane exposure medium before the secondary sustained
inhibition of dye transfer developed.
The lack of concordance between the recovery patterns for
Lucifer yellow dye transfer and uterine contractility, as
well as differences in the effective concentrations, may
suggest that lindane inhibits uterine contraction by a
mechanism other than interference with gap junctions.
Alternatively, the different recovery patterns and effective
concentrations may be related to differences between the
cell culture and muscle bath preparations. For example,
cellular characteristics often change in culture compared
with characteristics expressed in vivo or in tissue, so the
myometrial cells may respond differently to lindane in
cell culture than in tissue. Although the procedures used
in this study produce myometrial cell cultures that express
connexin43 [29], the gap junction protein that predomi-
nates in the pregnant uterus during parturition, regulation
of gap junctions may differ in cell cultures compared with
tissue. Moreover, the uptake, metabolism, and removal of
lindane may differ for cells in monolayer culture com-
pared with cells in multi-layered three-dimensional tissue
in a manner that allows for a different pattern of recovery.
The lowest observable effective concentration for sus-
tained inhibition of myometrial gap junction communi-
cation was 0.1 µM lindane, a concentration that matches
the average blood concentration of lindane (excluding an
"exceptionally high" value of 365 ppb) observed in a
cohort of women who gave birth to infants with
intrauterine growth retardation [17]. In contrast, inhibi-
tion of uterine contractility required lindane concentra-
tions several orders of magnitude greater than blood
concentrations reported in pregnant women [17,18].
Comparisons of experimental concentrations used in the
present study with human blood concentrations should
be made with caution, however, given the widely different
exposure conditions and widely different compositions of
blood, cell culture medium and muscle bath buffer. In a
previous study in which lindane was added to muscle
baths in a cumulative manner at 10-min intervals, uterine
strips exposed to 10 µM lindane accumulated 330 ppb lin-
dane, relative to wet weight [7]. Although 2000 ppb hex-
achlorocyclohexanes were reported in lipids extracted
from uteri of pregnant women [42], hexachlorocyclohex-
ane isomers were not identified individually and concen-
trations expressed on a lipid weight basis cannot be
compared directly to concentrations expressed relative to
wet weight.
Inhibition of contraction increased with time during a 1-
h exposure to lindane, suggesting that increased duration
of exposure may allow greater concentrations of lindane
to accumulate in the uterine tissue or may allow greater
Sustained inhibition of Lucifer yellow dye transfer following  lindane exposures of different durations Figure 7
Sustained inhibition of Lucifer yellow dye transfer fol-
lowing lindane exposures of different durations. Luci-
fer yellow dye transfer between myometrial cells was 
inhibited 24 h after initiating 10-min, 1-h or 24-h treatments 
with ethanol (solvent control) or 100 µM lindane. ANOVA, p 
≤ 0.0001. Mean values ± S.E.M. are shown (n = 5–8 culture 
dishes; 7–22 cells were injected per dish). Vertical bars with 
different letters have means that are significantly different 
from each other in pair-wise comparisons (Student-New-
man-Keuls, p ≤ 0.05).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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time for the development of the inhibitory response. The
time-dependent response to lindane suggests that acute in
vitro exposures may not show the maximal inhibition of
uterine contraction possible with continuous or long-
term exposures and that different concentration-response
curves may be observed with different exposure condi-
tions. This further supports the concern for caution in
extrapolating the results of the present study to human
exposures that may be longer in duration.
Studies investigating the mechanism of lindane-induced
inhibition of uterine contractility suggest that activation
of phospholipase C and generation of reactive oxygen
species are mechanistic links between inhibition of myo-
metrial gap junctions and inhibition of uterine contractil-
ity [2,4]. The latter studies led to the identification of a
previously unrecognized role for reactive oxygen species
in regulation of uterine contraction [2] and the partial
characterization of a previously unidentified myometrial
phospholipase A2 activity [4]. Although lindane's neuro-
toxicity is ascribed to inhibition of GABAA channels [9–
11], inhibition of GABAA channels in pregnant rat myo-
metrium by the GABAA channel inhibitor picrotoxin stim-
ulates contraction of uterine strips from gestation day 10
rats [7]. Because the picrotoxin response is opposite to the
inhibitory response observed with lindane, lindane-
induced inhibition of uterine contraction is likely medi-
ated by a mechanism independent of GABAA channel
inhibition. Previous studies in our laboratory showed that
lindane increases intracellular calcium concentration pri-
marily through release from IP3-sensitive intracellular
stores by a mechanism independent of L-type nifedipine-
sensitive calcium channels [43]. Although increased intra-
cellular calcium concentration does not mediate
myometrial inhibition of gap junction intercellular com-
munication [8], elevated calcium concentrations could,
Concentration-dependent effects of lindane on sustained inhibition of Lucifer yellow dye transfer Figure 8
Concentration-dependent effects of lindane on sustained inhibition of Lucifer yellow dye transfer. Lucifer yellow 
dye transfer between myometrial cells was inhibited in a concentration-dependent manner 24 h after initiating 1-h or 24-h 
treatments with 100 µM lindane (ANOVA, p ≤ 0.0001. Mean values ± S.E.M. are shown (n = 5–8 culture dishes; 7–22 cells 
were injected per dish). Vertical bars with different letters have means that are significantly different from each other in pair-
wise comparisons (Student-Newman-Keuls, p ≤ 0.05).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/62
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potentially, impair uterine contractility by a mechanism
other than inhibition of gap junctions. Furthermore, our
recent study found that lindane inhibited gap junction
intercellular communication by a mechanism independ-
ent of changes in the abundance and phosphorylation of
the gap junction protein connexin43 in rat myometrial
cells [44].
Additionally, in preliminary studies we have found that
simultaneous exposure of uterine tissues to lindane in
combination with either carbachol or oxytocin reduced
the force and oscillatory activity of spontaneously con-
tracting rat uterine strips compared with exposure to car-
bachol [45] or oxytocin alone (Goel and Loch-Caruso,
unpublished observations), consistent with previous
reports that lindane inhibits agonist-induced contractions
in vas deferens smooth muscle [32,33]. These preliminary
observations suggest that lindane interferes with agonist-
induced uterine contractility as well as spontaneous
contractility.
Although significant differences exist between the rat and
human uterus with respect to anatomy and early signals
leading to labor and delivery, the events of parturition
converge across the species at the level of the myometrium
as gestation nears term [1]. Because the increased forma-
tion of myometrial gap junctions is critical for parturition
in both rat and human [35], and lindane inhibited
myometrial gap junctions as well as uterine contractility,
the findings of the present study suggests that lindane may
have similar inhibitory actions in human myometrium.
Conclusions
The present study shows that in vitro exposure to lindane
interferes with myometrial functions that are necessary for
parturition, inhibiting spontaneous phasic contractions
in late gestation rat uterus and gap junction intercellular
communication in myometrial cell cultures. In addition,
the present study shows that lindane inhibits spontane-
ous phasic contractions and myometrial gap junction
intercellular communication in a sustained manner, sug-
gesting that even brief exposures of the uterus to lindane
may have long-lasting actions on uterine muscle function.
Lindane-induced inhibition of both myometrial gap junc-
tions and uterine contraction is consistent with a mecha-
nistic role for inhibition of myometrial gap junctions in
lindane-induced inhibition of uterine contraction. How-
ever, differences in effective lindane concentrations and
patterns of recovery from lindane-induced inhibition sug-
gest that mechanisms other than inhibition of myometrial
gap junctions, yet unidentified, may contribute to lin-
dane's actions on myometrial gap junctions and uterine
contraction.
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